NCT05438173View on ClinicalTrials.gov

Bioavailability of EPA/DHA in of Ruby-O and Krill Oil

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

September 18, 2022

Study Completion Date

September 18, 2022

Conditions
Bioavailability
Interventions
DIETARY_SUPPLEMENT

EPA + DHA Ruby-O

Subject will receive a single 1000 mg oral dose of EPA + DHA Ruby-O capsule

DIETARY_SUPPLEMENT

EPA + DHA Krill Oil

Subject will receive a single 1000 mg oral dose of EPA + DHA krill oil capsule

Trial Locations (1)

34952

Health Awareness, Port Saint Lucie

All Listed Sponsors
collaborator

Naturmega

UNKNOWN

lead

Midwest Center for Metabolic and Cardiovascular Research

OTHER